Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Liabilities and Shareholders Equity (2020 - 2025)

iSpecimen has reported Liabilities and Shareholders Equity over the past 6 years, most recently at $9.5 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 1.94% year-over-year to $9.5 million; the TTM value through Dec 2025 reached $31.4 million, down 30.25%, while the annual FY2025 figure was $9.5 million, 1.94% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $9.5 million at iSpecimen, up from $9.0 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $35.7 million in Q4 2021 and troughed at $6.0 million in Q2 2025.
  • A 5-year average of $17.7 million and a median of $16.3 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 475.22% in 2021 and later tumbled 49.3% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $35.7 million in 2021, then crashed by 31.08% to $24.6 million in 2022, then tumbled by 35.74% to $15.8 million in 2023, then tumbled by 40.89% to $9.4 million in 2024, then increased by 1.94% to $9.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for ISPC at $9.5 million in Q4 2025, $9.0 million in Q3 2025, and $6.0 million in Q2 2025.